Delivery Order SPE2DB22D3501-SPE2DB24FVW34

Award Date 6/4/24
Potential Completion Date 6/5/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,419.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,986,533 units of Metronidazole 500 mg Tablets, a generic medication used to treat various bacterial and parasitic infections. This Delivery Order contract has a firm fixed price and an ultimate completion date of January 22, 2025. The contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,061.88 firm fixed price delivery order is for the supply of 500 mg metronidazole tablets, a generic antibiotic medication. The award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,263 units of 500 mg Metronidazole tablets. The Firm Fixed Price delivery order, valued at $1,378.43, has a period of performance through July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to supply a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.25 delivery order contract is for the supply of Metronidazole 500 mg tablets, a medication used to treat certain bacterial and parasitic infections. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,023.82 firm fixed-price delivery order is for the supply of Metronidazole 250 mg tablets, a critical antibiotic medication. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, which enables the government to efficiently procure a comprehensive range of...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $2,119.70 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Metronidazol 250mg tablets, a generic medication used to treat various bacterial and parasitic infections. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FZ80X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Metronidazole 500 mg tablets, a generic antibiotic medication, with a ceiling value of $1,348.74 and a period of performance through January 22, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not...
This federal contract award, valued at $2,225.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,583 units of Metronidazole 500 mg tablets. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 25, 2023. The contract was awarded on October 24, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order contract (SPE2DB22D1106|SPE2DB25FDJJ3) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 500 mg Metronidazole tablets, with a ceiling value of $8,577.24 and a period of performance through October 31, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order, valued at $1,046.90, is for the supply of Metronidazole Tablets, a pharmaceutical product, to support military treatment programs and facilities. The award has no set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVW34
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $2,645.42, is for the delivery of 4,564,803,623 tablets of Metronidazole 500 mg, a generic antibiotic medication. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of June 5, 2024.

The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This contract does not have a set-aside designation, as it was awarded on a full and open competition basis. Amerisourcebergen's expertise in pharmaceutical distribution and its extensive supply chain network enable it to efficiently fulfill these types of government contracts for critical medical products.

Generated 9/3/24, 11:59 AM